These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 26832884)
1. Optimal Surgical Management for Occult Breast Carcinoma: A Meta-analysis. Macedo FI; Eid JJ; Flynn J; Jacobs MJ; Mittal VK Ann Surg Oncol; 2016 Jun; 23(6):1838-44. PubMed ID: 26832884 [TBL] [Abstract][Full Text] [Related]
2. Treatment outcomes and unfavorable prognostic factors in patients with occult breast cancer. He M; Tang LC; Yu KD; Cao AY; Shen ZZ; Shao ZM; Di GH Eur J Surg Oncol; 2012 Nov; 38(11):1022-8. PubMed ID: 22959166 [TBL] [Abstract][Full Text] [Related]
3. Surgical Management of the Axilla in Patients with Occult Breast Cancer (cT0 N+) After Neoadjuvant Chemotherapy. Cohen BL; Collier AL; Kelly KN; Goel N; Kesmodel SB; Yakoub D; Moller M; Avisar E; Franceschi D; Macedo FI Ann Surg Oncol; 2020 Jun; 27(6):1830-1841. PubMed ID: 31989360 [TBL] [Abstract][Full Text] [Related]
4. Best treatment options for occult breast cancer: A meta-analysis. Wang R; Yang HX; Chen J; Huang JJ; Lv Q Front Oncol; 2023; 13():1051232. PubMed ID: 37251927 [TBL] [Abstract][Full Text] [Related]
5. Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective study. Sohn G; Son BH; Lee SJ; Kang EY; Jung SH; Cho SH; Baek S; Lee YR; Kim HJ; Ko BS; Yu ; Lee JW; Ahn SH J Surg Oncol; 2014 Sep; 110(3):270-4. PubMed ID: 24863883 [TBL] [Abstract][Full Text] [Related]
6. Routine completion axillary lymph node dissection for positive sentinel nodes in patients undergoing mastectomy is not associated with improved local control. Crawford JD; Ansteth M; Barnett J; Glissmeyer M; Johnson NG Am J Surg; 2013 May; 205(5):581-4; discussion 584. PubMed ID: 23592166 [TBL] [Abstract][Full Text] [Related]
7. Surgical management of early stage invasive breast cancer: a practice guideline. McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ; Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621 [TBL] [Abstract][Full Text] [Related]
8. Conservative axillary surgery in breast cancer patients undergoing mastectomy: long-term results. Cowher MS; Grobmyer SR; Lyons J; O'Rourke C; Baynes D; Crowe JP J Am Coll Surg; 2014 Apr; 218(4):819-24. PubMed ID: 24655877 [TBL] [Abstract][Full Text] [Related]
9. Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer? Fu Y; Chung D; Cao MA; Apple S; Chang H Ann Surg Oncol; 2014 Dec; 21(13):4109-23. PubMed ID: 25081336 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy. FitzSullivan E; Bassett RL; Kuerer HM; Mittendorf EA; Yi M; Hunt KK; Babiera GV; Caudle AS; Black DM; Bedrosian I; Reyna C; Teshome M; Meric-Bernstam F; Hwang R Ann Surg Oncol; 2017 Mar; 24(3):652-659. PubMed ID: 27822630 [TBL] [Abstract][Full Text] [Related]
11. Outcomes with and without axillary node dissection for node-positive lumpectomy and mastectomy patients. Snow R; Reyna C; Johns C; Lee MC; Sun W; Fulp WJ; Kiluk JV; Laronga C Am J Surg; 2015 Oct; 210(4):685-93. PubMed ID: 26210706 [TBL] [Abstract][Full Text] [Related]
12. Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes. Bonneau C; Hequet D; Estevez JP; Pouget N; Rouzier R Eur J Surg Oncol; 2015 Aug; 41(8):998-1004. PubMed ID: 25986854 [TBL] [Abstract][Full Text] [Related]
13. Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients. Kobayashi R; Shiraishi K; Iwase S; Ohtomo K; Nakagawa K Breast Cancer; 2015 Nov; 22(6):657-63. PubMed ID: 24756246 [TBL] [Abstract][Full Text] [Related]
14. Axillary lymph node dissection plus radiotherapy may be an optimal strategy for patients with occult breast cancer. Li L; Zhang D; Wen T; Wu Y; Lv D; Zhai J; Ma F J Natl Cancer Cent; 2022 Dec; 2(4):198-204. PubMed ID: 39036544 [TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Olson JA; Morris EA; Van Zee KJ; Linehan DC; Borgen PI Ann Surg Oncol; 2000 Jul; 7(6):411-5. PubMed ID: 10894136 [TBL] [Abstract][Full Text] [Related]
16. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968 [TBL] [Abstract][Full Text] [Related]
17. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290 [TBL] [Abstract][Full Text] [Related]
18. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ. Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180 [TBL] [Abstract][Full Text] [Related]
19. Management of contralateral axillary lymph node metastasis from breast cancer: a clinical dilemma. Wang W; Yuan P; Wang J; Ma F; Zhang P; Li Q; Xu B Tumori; 2014; 100(6):600-4. PubMed ID: 25688492 [TBL] [Abstract][Full Text] [Related]
20. Treatment outcomes of occult breast carcinoma and prognostic analyses. Wang J; Zhang YF; Wang X; Wang J; Yang X; Gao YQ; Fang Y Chin Med J (Engl); 2013 Aug; 126(16):3026-9. PubMed ID: 23981605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]